close

Clinical Trials

1 218 219 220
Number of results: 4391

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2008-03-05 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 1 Advantagene (USA - MA) Cancer - Oncology
2007-12-27 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 2a Advantagene (USA - MA) Cancer - Oncology
0000-00-00 ETS2101 (dexanabinol) Cancer - Oncology
0000-00-00 IMCgp100 uveal melanoma 1 Immunocore (UK) Cancer - Oncology
0000-00-00 delafloxacin acute bacterial skin and skin structure infections (ABSSSI) 3 Melinta Therapeutics (USA - CT) Infectious diseases
0000-00-00 acute bacterial skin and skin structure infections (ABSSSI) Infectious diseases
0000-00-00 ESKAPE Pathogen Program including RX-P873 preclinical Melinta Therapeutics (USA - CT) Infectious diseases
0000-00-00 triheptanoin (UX007) Glut1 DS - Encephalopathy due to GLUT1 deficiency 3 Ultragenyx Pharmaceutical (USA - CA) Rare diseases - CNS diseases - Neurological diseases
0000-00-00 brilacidin ulcerative proctitis/ulcerative proctosigmoiditis 2 Cellceutix (USA - MA), now Innovation Pharmaceuticals (USA - MA) Inflammatory diseases
0000-00-00 NV556 NASH (non-alcoholic steatohepatitis) preclinical Neurovive Pharmaceutical (Sweden) Liver diseases - Hepatic diseases
0000-00-00 psoriasis Merck&Co (USA - NJ) Sun Pharmaceutical Industries (India) Autoimmune diseases - Dermatological diseases - Inflammatory diseases